₹5
(Inclusive of all Taxes)
₹0.3 Cashback (5%)
coupon
Prescription drugWhats That
Composition :
BETAMETHASONE-4MG
Manufacturer/Marketer :
Intas Pharmaceuticals Ltd
Consume Type :
PARENTERAL
Return Policy :
Not Returnable
Expires on or after :
Secure Payment
Trusted by 8 Crore Indians
Genuine Products
Author Details
_0.jpg?tr=q-80,f-webp,w-100,dpr-6,c-at_max "Santoshini Reddy G")
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Customers Also Bought
Alcohol
Unsafe
You are recommended to avoid alcohol consumption with Betni Injection 1 ml as it may increase the risk of ulcers.
Pregnancy
Caution
Betni Injection 1 ml is given to pregnant women only if the doctor thinks the benefits outweigh the risks. If you are pregnant while using Betni Injection 1 ml, inform your doctor and do not stop the treatment unless advised by the doctor.
Breast Feeding
Caution
Betni Injection 1 ml is excreted in human milk and may lower hormone levels in the baby if Betni Injection 1 ml is used in high doses for a long duration. Therefore, before prescribing Betni Injection 1 ml to a breastfeeding mother, your doctor will discuss the benefits and risks of using it.
Driving
Safe if prescribed
Betni Injection 1 ml usually does not affect your ability to drive or operate machinery.
Liver
Caution
Take Betni Injection 1 ml with caution, especially if you have a history of Liver diseases/conditions. The dose may be adjusted by your doctor as required.
Kidney
Caution
Take Betni Injection 1 ml with caution, especially if you have a history of Kidney diseases/conditions. The dose may be adjusted by your doctor as required.
Children
Caution
Betni Injection 1 ml is given to children in doses advised by a doctor based on their age. Betni Injection 1 ml may affect the growth of children. Therefore, inform your doctor if your child is not growing at a normal rate while using Betni Injection 1 ml.
Product Substitutes
Drug-Drug Interactions
BetamethasoneIohexol
Critical
Critical
Drug-Drug Interactions
Login/Sign Up
BetamethasoneIohexol
Critical
How does the drug interact with Betni Injection 1 ml:
Co-administration of Iohexol and Betni Injection 1 ml can increase the risk of seizures.
How to manage the interaction:
Taking Betni Injection 1 ml with Iohexol is not recommended, please consult your doctor before taking it.
Co-administration of Iohexol and Betni Injection 1 ml can increase the risk of seizures.
How to manage the interaction:
Taking Betni Injection 1 ml with Iohexol is not recommended, please consult your doctor before taking it.
Critical
How does the drug interact with Betni Injection 1 ml:
Co-administration of Desmopressin with Betni Injection 1 ml can increase the risk of hyponatremia (low levels of salt in the blood).
How to manage the interaction:
Co-administration of Betni Injection 1 ml and Desmopressin can lead to an interaction, it can be taken if advised by a doctor. However, if you experience any symptoms like loss of appetite, nausea, vomiting, headache, lethargy, irritability, difficulty concentrating, memory impairment, confusion, muscle spasm, weakness, unsteadiness, decreased urination, and/or sudden weight gain, consult a doctor immediately. Do not stop using any medications without a doctor's advice.
Co-administration of Desmopressin with Betni Injection 1 ml can increase the risk of hyponatremia (low levels of salt in the blood).
How to manage the interaction:
Co-administration of Betni Injection 1 ml and Desmopressin can lead to an interaction, it can be taken if advised by a doctor. However, if you experience any symptoms like loss of appetite, nausea, vomiting, headache, lethargy, irritability, difficulty concentrating, memory impairment, confusion, muscle spasm, weakness, unsteadiness, decreased urination, and/or sudden weight gain, consult a doctor immediately. Do not stop using any medications without a doctor's advice.
BetamethasoneMetrizamide
Critical
How does the drug interact with Betni Injection 1 ml:
Co-administration of Metrizamide and Betni Injection 1 ml can increase the risk of seizure.
How to manage the interaction:
Taking Betni Injection 1 ml with Metrizamide is not recommended, please consult your doctor before taking it.
Co-administration of Metrizamide and Betni Injection 1 ml can increase the risk of seizure.
How to manage the interaction:
Taking Betni Injection 1 ml with Metrizamide is not recommended, please consult your doctor before taking it.
BetamethasoneIopamidol
Critical
How does the drug interact with Betni Injection 1 ml:
Co-administration of Iopamidol and Betni Injection 1 ml can increase the risk of seizure.
How to manage the interaction:
Taking Betni Injection 1 ml with Iopamidol is not recommended, please consult your doctor before taking it.
Co-administration of Iopamidol and Betni Injection 1 ml can increase the risk of seizure.
How to manage the interaction:
Taking Betni Injection 1 ml with Iopamidol is not recommended, please consult your doctor before taking it.
Critical
How does the drug interact with Betni Injection 1 ml:
Co-administration of Betni Injection 1 ml with Mifepristone may significantly reduce the effect of Betni Injection 1 ml which may be less effective as a therapy.
How to manage the interaction:
Taking Betni Injection 1 ml with mifepristone together can result in an interaction, it can be taken if a doctor has advised it. Contact a doctor immediately if you experience any unusual symptoms. Do not discontinue any medications without consulting a doctor.
Co-administration of Betni Injection 1 ml with Mifepristone may significantly reduce the effect of Betni Injection 1 ml which may be less effective as a therapy.
How to manage the interaction:
Taking Betni Injection 1 ml with mifepristone together can result in an interaction, it can be taken if a doctor has advised it. Contact a doctor immediately if you experience any unusual symptoms. Do not discontinue any medications without consulting a doctor.
BetamethasoneIomeprol
Critical
How does the drug interact with Betni Injection 1 ml:
Co-administration of Iomeprol and Betni Injection 1 ml can increase the risk of seizures.
How to manage the interaction:
Taking Betni Injection 1 ml with Iomeprol is not recommended, please consult your doctor before taking it.
Co-administration of Iomeprol and Betni Injection 1 ml can increase the risk of seizures.
How to manage the interaction:
Taking Betni Injection 1 ml with Iomeprol is not recommended, please consult your doctor before taking it.
Severe
How does the drug interact with Betni Injection 1 ml:
Co-administration of Vigabatrin with Betni Injection 1 ml may increase the risk of serious side effects associated with vision loss, especially if used together for prolonged periods.
How to manage the interaction:
Although there is an interaction, Betni Injection 1 ml can be taken with vigabatrin if prescribed by the doctor. Routine vision testing is advised during treatment with vigabatrin. Do not discontinue any medications without a doctor's advice.
Co-administration of Vigabatrin with Betni Injection 1 ml may increase the risk of serious side effects associated with vision loss, especially if used together for prolonged periods.
How to manage the interaction:
Although there is an interaction, Betni Injection 1 ml can be taken with vigabatrin if prescribed by the doctor. Routine vision testing is advised during treatment with vigabatrin. Do not discontinue any medications without a doctor's advice.
Severe
How does the drug interact with Betni Injection 1 ml:
Co-administration of Leflunomide with Betni Injection 1 ml may increase the risk of serious infections.
How to manage the interaction:
Although there is an interaction, Betni Injection 1 ml can be taken with leflunomide if prescribed by the doctor. Contact the prescriber immediately if you develop signs and symptoms of infection such as fever, chills, diarrhea, sore throat, muscle aches, shortness of breath, blood in phlegm, weight loss, red or inflamed skin, body sores, pain or burning during urination. Do not discontinue the medication without consulting a doctor.
Co-administration of Leflunomide with Betni Injection 1 ml may increase the risk of serious infections.
How to manage the interaction:
Although there is an interaction, Betni Injection 1 ml can be taken with leflunomide if prescribed by the doctor. Contact the prescriber immediately if you develop signs and symptoms of infection such as fever, chills, diarrhea, sore throat, muscle aches, shortness of breath, blood in phlegm, weight loss, red or inflamed skin, body sores, pain or burning during urination. Do not discontinue the medication without consulting a doctor.
Severe
How does the drug interact with Betni Injection 1 ml:
Co-administration of Norfloxacin may cause tendinitis (inflammation of the muscle to bone) and tendon rupture (injuries to the soft tissues that connect muscles and joints), and the risk may be increased when combined with Betni Injection 1 ml.
How to manage the interaction:
Taking Norfloxacin with Betni Injection 1 ml together can result in an interaction, it can be taken if a doctor has advised it. However, if you experience Stiff joints or difficulty moving your joints, joint pains, Swelling, or skin discoloration, contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
Co-administration of Norfloxacin may cause tendinitis (inflammation of the muscle to bone) and tendon rupture (injuries to the soft tissues that connect muscles and joints), and the risk may be increased when combined with Betni Injection 1 ml.
How to manage the interaction:
Taking Norfloxacin with Betni Injection 1 ml together can result in an interaction, it can be taken if a doctor has advised it. However, if you experience Stiff joints or difficulty moving your joints, joint pains, Swelling, or skin discoloration, contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with Betni Injection 1 ml:
Co-administration of Betni Injection 1 ml with Bupropion may increase the risk of seizures associated with Bupropion.
How to manage the interaction:
Although there is an interaction, Betni Injection 1 ml can be taken with Bupropion if prescribed by the doctor. Do not discontinue any medication without consulting a doctor.
Co-administration of Betni Injection 1 ml with Bupropion may increase the risk of seizures associated with Bupropion.
How to manage the interaction:
Although there is an interaction, Betni Injection 1 ml can be taken with Bupropion if prescribed by the doctor. Do not discontinue any medication without consulting a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Drug-Diseases Interactions
BETAMETHASONE-4MGOther and unspecified infectious diseases
Severe
BETAMETHASONE-4MGCarrier of infectious disease
Moderate
Drug-Diseases Interactions
Login/Sign Up
BETAMETHASONE-4MGOther and unspecified infectious diseases
Severe
How does the disease interact with Betni Injection 1 ml:
Corticosteroids' immunosuppressive and anti-inflammatory properties, especially when used in larger doses, have the potential to reduce host resistance to pathogens, impair the ability to localise infections, and disguise infection-related symptoms. Perhaps secondary infections are more likely to occur. In general, individuals with active infections—especially systemic fungal infections—should not be treated with corticosteroids.
How to manage the interaction:
Betni Injection 1 ml may lower the host resistance to infectious agents, decrease the ability to localize infections, and mask the symptoms of infection. Secondary infections may also develop. It should not be used in patients with active infections unless medically necessary.
Corticosteroids' immunosuppressive and anti-inflammatory properties, especially when used in larger doses, have the potential to reduce host resistance to pathogens, impair the ability to localise infections, and disguise infection-related symptoms. Perhaps secondary infections are more likely to occur. In general, individuals with active infections—especially systemic fungal infections—should not be treated with corticosteroids.
How to manage the interaction:
Betni Injection 1 ml may lower the host resistance to infectious agents, decrease the ability to localize infections, and mask the symptoms of infection. Secondary infections may also develop. It should not be used in patients with active infections unless medically necessary.
BETAMETHASONE-4MGCarrier of infectious disease
Moderate
How does the disease interact with Betni Injection 1 ml:
Pharmacologic doses of corticosteroids may reactivate latent tuberculosis in people who have it or who are tuberculin-reactive. If corticosteroid medication is given to individuals with a history of TB or tuberculin reactivity, close monitoring for signs and symptoms of tuberculosis is advised. Consideration may be given to tuberculosis chemoprophylaxis when receiving prolonged corticosteroid medication.
How to manage the interaction:
Betni Injection 1 ml may cause a reactivation of the disease in patients with latent tuberculosis. It is advised to closely monitor for signs and symptoms of tuberculosis such as cough, tiredness, loss of appetite, and fever.
Pharmacologic doses of corticosteroids may reactivate latent tuberculosis in people who have it or who are tuberculin-reactive. If corticosteroid medication is given to individuals with a history of TB or tuberculin reactivity, close monitoring for signs and symptoms of tuberculosis is advised. Consideration may be given to tuberculosis chemoprophylaxis when receiving prolonged corticosteroid medication.
How to manage the interaction:
Betni Injection 1 ml may cause a reactivation of the disease in patients with latent tuberculosis. It is advised to closely monitor for signs and symptoms of tuberculosis such as cough, tiredness, loss of appetite, and fever.
BETAMETHASONE-4MGFibrosis and cirrhosis of liver
Moderate
How does the disease interact with Betni Injection 1 ml:
Due to a reduced rate of metabolism, corticosteroids may have a greater impact on cirrhotic patients. Cirrhotic patients should have their cortisol levels constantly monitored. In some people, dosage modifications might be necessary.
How to manage the interaction:
Betni Injection 1 ml may have enhanced effects in patients with cirrhosis. Monitoring the condition of patients with cirrhosis is advised.
Due to a reduced rate of metabolism, corticosteroids may have a greater impact on cirrhotic patients. Cirrhotic patients should have their cortisol levels constantly monitored. In some people, dosage modifications might be necessary.
How to manage the interaction:
Betni Injection 1 ml may have enhanced effects in patients with cirrhosis. Monitoring the condition of patients with cirrhosis is advised.
BETAMETHASONE-4MGDepressive episode
Moderate
How does the disease interact with Betni Injection 1 ml:
Psychotic and emotional instability symptoms may be increased severely by corticosteroids. During corticosteroid medication, patients with these disorders should be watched for any worsening or intensification of their symptoms.
How to manage the interaction:
Betni Injection 1 ml may elevate the symptoms of psychosis and emotional instability. Monitoring of patients with these conditions for increased or worsened symptoms is recommended.
Psychotic and emotional instability symptoms may be increased severely by corticosteroids. During corticosteroid medication, patients with these disorders should be watched for any worsening or intensification of their symptoms.
How to manage the interaction:
Betni Injection 1 ml may elevate the symptoms of psychosis and emotional instability. Monitoring of patients with these conditions for increased or worsened symptoms is recommended.
BETAMETHASONE-4MGType 1 diabetes mellitus
Moderate
How does the disease interact with Betni Injection 1 ml:
By opposing the effect of insulin and inhibiting its secretion, corticosteroids can increase blood sugar levels. This inhibits peripheral glucose uptake and increases gluconeogenesis. Patients with diabetes mellitus, glucose intolerance, or a tendency for hyperglycemia should receive corticosteroid therapy with caution. During corticosteroid medication, patients with diabetes mellitus should be monitored more carefully, and their anti-diabetic regimen should be changed correspondingly.
How to manage the interaction:
Betni Injection 1 ml may raise blood glucose levels. Monitoring of blood sugar levels in patients with diabetes is advised.
By opposing the effect of insulin and inhibiting its secretion, corticosteroids can increase blood sugar levels. This inhibits peripheral glucose uptake and increases gluconeogenesis. Patients with diabetes mellitus, glucose intolerance, or a tendency for hyperglycemia should receive corticosteroid therapy with caution. During corticosteroid medication, patients with diabetes mellitus should be monitored more carefully, and their anti-diabetic regimen should be changed correspondingly.
How to manage the interaction:
Betni Injection 1 ml may raise blood glucose levels. Monitoring of blood sugar levels in patients with diabetes is advised.
BETAMETHASONE-4MGOther disorders of fluid, electrolyte and acid-base balance
Moderate
How does the disease interact with Betni Injection 1 ml:
Hypernatremia, hypokalemia, and fluid retention are side effects of corticosteroids. Patients who already have electrolyte abnormalities should use corticosteroids with caution. Additionally, care should be taken while managing patients with seizure disorders since electrolyte imbalances might result in seizure activity.
How to manage the interaction:
Betni Injection 1 ml may cause fluid retention, low potassium, and high sodium levels. Caution is advised in patients with electrolyte disturbances.
Hypernatremia, hypokalemia, and fluid retention are side effects of corticosteroids. Patients who already have electrolyte abnormalities should use corticosteroids with caution. Additionally, care should be taken while managing patients with seizure disorders since electrolyte imbalances might result in seizure activity.
How to manage the interaction:
Betni Injection 1 ml may cause fluid retention, low potassium, and high sodium levels. Caution is advised in patients with electrolyte disturbances.
BETAMETHASONE-4MGOedema, not elsewhere classified
Moderate
How does the disease interact with Betni Injection 1 ml:
Hypernatremia, hypokalemia, fluid retention, and an increase in blood pressure are all possible side effects of corticosteroids. Patients who already have fluid retention, hypertension, congestive heart failure, and/or renal impairment should use corticosteroids with caution. Potassium supplements and dietary salt control may be advised.
How to manage the interaction:
Betni Injection 1 ml may cause fluid retention, low potassium, high sodium levels, and elevated blood pressure. Caution is advised in patients with pre-existing fluid retention, high blood pressure, congestive heart failure, and/or kidney dysfunction.
Hypernatremia, hypokalemia, fluid retention, and an increase in blood pressure are all possible side effects of corticosteroids. Patients who already have fluid retention, hypertension, congestive heart failure, and/or renal impairment should use corticosteroids with caution. Potassium supplements and dietary salt control may be advised.
How to manage the interaction:
Betni Injection 1 ml may cause fluid retention, low potassium, high sodium levels, and elevated blood pressure. Caution is advised in patients with pre-existing fluid retention, high blood pressure, congestive heart failure, and/or kidney dysfunction.
Have a query?